UK-based genomics data platform Global Gene Corp and American genetics company, Regeneron Genetics Center announced yesterday that they will collaborate to create the world’s largest project of its kind to study Indian population.
The multi-year-tie-up is aimed at finding innovative diagnosis and therapies for rare diseases. Genomic sequencing data generated by Regeneron Research Center will be paired with de-identified medical records from consenting patients to examine links between human genetic variations and disease.
“We’re working to solve the problem of genomic bias…”
“The genomics revolution is crucial to the delivery of improved healthcare for all. We are working to solve the problem of genomic data bias where 81 percent of genomics data comes from Caucasian populations of Europen ancestry; India with 1.3 billion people represents 20 percent of the world’s population, yet her population contributes less than 1 percent of genomic data and insights,” said Sumit Jamuar, Chairman and CEO, Global Gene Corp.
“A deeper understanding of the genetic architecture and disease burden in populations throughout the Indian sub-continent will enable the identification of novel genes associated with many rare and common diseases, potentially facilitating therapeutic development, diagnosis and delivery of precision medicine”, said Alan Shuldiner, MD, VP, and Head of Founder and Special Populations at the Regeneron Genetics Center.
Read the full article at frontlinegenomics